EP0784437A1 - Melange de graisses contenant des phospholipides avec des acides gras polyinsatures a longue chaine - Google Patents
Melange de graisses contenant des phospholipides avec des acides gras polyinsatures a longue chaineInfo
- Publication number
- EP0784437A1 EP0784437A1 EP95934657A EP95934657A EP0784437A1 EP 0784437 A1 EP0784437 A1 EP 0784437A1 EP 95934657 A EP95934657 A EP 95934657A EP 95934657 A EP95934657 A EP 95934657A EP 0784437 A1 EP0784437 A1 EP 0784437A1
- Authority
- EP
- European Patent Office
- Prior art keywords
- fatty acids
- phospholipids
- fat
- arachidonic acid
- acid
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23C—DAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; MAKING THEREOF
- A23C11/00—Milk substitutes, e.g. coffee whitener compositions
- A23C11/02—Milk substitutes, e.g. coffee whitener compositions containing at least one non-milk component as source of fats or proteins
- A23C11/04—Milk substitutes, e.g. coffee whitener compositions containing at least one non-milk component as source of fats or proteins containing non-milk fats but no non-milk proteins
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23D—EDIBLE OILS OR FATS, e.g. MARGARINES, SHORTENINGS, COOKING OILS
- A23D9/00—Other edible oils or fats, e.g. shortenings, cooking oils
- A23D9/007—Other edible oils or fats, e.g. shortenings, cooking oils characterised by ingredients other than fatty acid triglycerides
- A23D9/013—Other fatty acid esters, e.g. phosphatides
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/115—Fatty acids or derivatives thereof; Fats or oils
- A23L33/12—Fatty acids or derivatives thereof
Definitions
- the invention relates to a formula food containing a fat mixture based on animal and vegetable including microbial oils and / or fats and lecithins containing long-chain, highly unsaturated fatty acids as well as a fat mixture of this type for producing a formula food.
- LCP fatty acids Long-chain, highly unsaturated fatty acids with in particular 20 to 22 carbon atoms, so-called LCP fatty acids, are synthesized in the human organism by chain extension and desaturation from the essential fatty acids linoleic and linolenic acid. Accordingly, the linoleic acid (18-2w6) and the ⁇ -linolenic acid (18-3w3), which are a w6- and w3-desaturated fatty acid, have to be ingested with the diet.
- the linoleic acid is the starting compound for the group of w6-LCP-, while the ⁇ -lin ⁇ lenic acid is the starting compound for the group of w3-LCP-fatty acids.
- LCP fatty acids of which arachidonic acid (AA; 20-4w6) and docosahexaenoic acid (DHA; 22-6w3) are of the greatest importance, are found in the brain to a considerable extent, especially in the last third of pregnancy and in the first months after birth accumulated.
- Prenatal LCP fatty acids are made available to the fetus through the placenta. After birth, the infant receives these fatty acids with the mother's milk, because human milk contains both w6- and w3-LCP, with arachidonic and docosahexaenoic acids being the most important quantitative components.
- Formula foods or baby foods containing such LCP fatty acids are already known; in this regard, reference is made to EP-A 0 404 058, EP-A 0 231 904 and US-A 4 670 285.
- the contents of the LCP fatty acids are more or less close to the values of the total lipids approximated by breast milk.
- the amount of the supplemented LCP fatty acids is used, but not the form in which these fatty acids are bound.
- the total lipids in breast milk are composed of approximately 97 to 99% triacylglycerides and approximately 0.5 to 2% phospholipids.
- free fatty acids, mono- and diacylglycerides, glycolipids and cholesterol and phytosterols also occur in breast milk.
- the LCP fatty acids in breast milk are approximately 90 to 95% in the form of triglycerides and approximately 5 to 10% in the form of phospholipids.
- EP-A-0 484 266 takes the incorrect view that the majority of the long-chain, highly unsaturated fatty acids (LCP fatty acids) are present in human milk in the form of phospholipids.
- LCP fatty acids in the form of phospholipids from the brain fat of mammals to dietary foods is therefore recommended there.
- the LCP contents of fish oil are also adapted to the ratios of the total lipids in breast milk.
- the object of the present invention is to provide an improved formula food and an improved fat mixture for the production of this formula food which comes as close as possible to the nutritional quality of breast milk.
- the formulas or fat blends representing the state of the art are adjusted (in absolute terms) to the ratios of the total lipids from breast milk in terms of the LCP fatty acids of interest here. It has now surprisingly been found that the total amount of LCP fatty acids in the formula can be reduced if the arachidonic acid and docosahexaenoic acid are partly available in the form of phospholipids in the amount according to the invention.
- the addition of LCP fatty acids in the form of tri-glycerides as is the case with the known formula foods, can thus be considerably reduced and the costs for supplementation with LCP fatty acids can thereby be reduced.
- Arachidonic acid both in triglyceride form and in phospholipid form, is added to a formula in the amounts claimed according to the invention.
- the weight ratio of the arachidonic acid present in the form of triglycerides to the docosahexaenoic acid present in the form of triglycerides is 0.5: 1 to 20: 1.
- the weight ratio of arachidonic acid present in the form of phospholipids to docosahexaenoic acid present in the form of phospholipids is preferably 0.5: 1 to 1: 5.
- the arachidonic acid and the docosahexaenoic acid are preferably in the form of phosphoglycerolipids, more preferably in the form of phosphatidylcholine and phosphatidylethanolamine.
- the invention further relates to a fat mixture which contains the LCP fatty acids in the stated form and in the stated amounts.
- This fat mixture is suitable for the production of baby and premature baby food, in particular baby milk food.
- formula food is understood to mean any "artificial" formula food that is produced without the use of human milk or without the use of the components of human milk.
- the formula food according to the invention and of course also the fat mixture according to the invention can be produced by:
- Animal and vegetable oils and fats containing triacylglycerides are mixed with animal, vegetable and / or microbial phospholipids (lecithins) which contain LCP fatty acids.
- Animal fats can be, for example, butterfat, organ fats such as kidney, liver and brain fat, and
- Oils from mono- and dicotyledonous plants can be used as vegetable oils.
- oils from microbial origin (SCO) or algae and mushroom oils can be used.
- the LCP fatty acids arachidonic and docosahexaenoic acid used in the form of phospholipids are introduced into the fat mixture or formula food according to the invention in the form of phospholipids of animal, vegetable and microbial origin.
- These phospholipids include lecithins from fish, from other marine organisms, such as mammals, krill, cephalopods, etc., from egg lipids, from animal brain and other organ lipids and from macro and microalgae and / or from microorganisms .
- a finished formula eg infant milk
- a fat content 4% or 4 g / 100 ml
- the arachidonic acid present in the form of phospholipids makes 0.6 to 15 mg and the Docosahexaenoic acid present in the form of phospholipids from 0.3 to 10 mg per 100 ml of formula food.
- the invention also relates to a method for producing a fat mixture according to the invention.
- animal, vegetable and / or microbial oils and / or fats which contain no LCP fatty acids or only low LCP fatty acid fractions (in particular, these are fats and oils which have been used previously for the production of non-LCP) - Fatty acids supplemented formula foods were used), with a source of arachidonic acid and docosahexaenic acid, which are in the form of phospholipids, or with animal, vegetable, including microbial oils, fats and / or lecithins, the arachidonic acid and docosahexaenoic acid in Contain form of phospholipids, mixed in a known manner such that these arachidonic acid and docosahexaenoic acid meet the values specified in claims 1 to 4.
- oils, fats and / or lecithins can be mixed according to the prior art; in this regard, reference is made, for example, to EP-A 0 231 904 and EP-A 0 404 058.
- a formula food can also be produced from this fat mixture according to the prior art.
- Table 1 below shows the composition of five fat mixtures according to the invention and the resulting fatty acid pattern. These fat mixtures are produced by mixing the fat raw materials listed in Table 1.
- Table 2 shows the composition of various formula foods according to the invention, which were produced using the fat mixtures explained in Table 1. To produce the formula foods listed in Table 2, the constituents shown there are mixed with one another. Ready-to-drink formula foods can be made from it by adding drinking water. 13 g of the composition or formula described in Table 2 are added to 90 ml of drinking water and mixed. 100 ml of the ready-to-drink formula foods obtained in this way have the absolute contents of the fatty acids mentioned there in Table 3 which follows. The short designation or nomenclature for the fatty acids used in the present documents is explained in more detail, inter alia, in "Lipid Analysis” by William W. Christie, Pergamon Press, 1973.
- composition of several fat mixtures according to the invention and the resulting fatty acid pattern (data in% by weight)
- Example 1 Example 2 Example 3 Example 4 Example 5
- Sunflower oil (hyp.) 10 10 10 10 10 10 palm oil 25 24 21.5 21.5 21.5 coconut / palm kernel fat 14 13 12 10 7 canola oil 5 5 5 5 5 soy oil 14 13.5 13.5 11.5 9.5 Lecithin 1 2 4 8 12 17
- composition of various formula foods according to the invention (details in g)
- Example 1 Example 2 Example 3 Example 4 Example 5
- DHA Docosahexaenic acid
- Example 1 Example 2 Example 3 Example 4 Example 5
- DHA Docosahexaenoic acid
Landscapes
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Polymers & Plastics (AREA)
- Food Science & Technology (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Mycology (AREA)
- Nutrition Science (AREA)
- Health & Medical Sciences (AREA)
- Fats And Perfumes (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
- Dairy Products (AREA)
- Edible Oils And Fats (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE4435535 | 1994-10-05 | ||
DE4435535 | 1994-10-05 | ||
PCT/EP1995/003899 WO1996010922A1 (fr) | 1994-10-05 | 1995-10-02 | Melange de graisses contenant des phospholipides avec des acides gras polyinsatures a longue chaine |
Publications (2)
Publication Number | Publication Date |
---|---|
EP0784437A1 true EP0784437A1 (fr) | 1997-07-23 |
EP0784437B1 EP0784437B1 (fr) | 1998-07-08 |
Family
ID=6529982
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EP95934657A Expired - Lifetime EP0784437B1 (fr) | 1994-10-05 | 1995-10-02 | Melange de graisses contenant des phospholipides avec des acides gras polyinsatures a longue chaine |
Country Status (8)
Country | Link |
---|---|
EP (1) | EP0784437B1 (fr) |
JP (1) | JPH10508193A (fr) |
AT (1) | ATE167983T1 (fr) |
CA (1) | CA2201931C (fr) |
DE (1) | DE59502779D1 (fr) |
DK (1) | DK0784437T3 (fr) |
ES (1) | ES2118629T3 (fr) |
WO (1) | WO1996010922A1 (fr) |
Families Citing this family (21)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6080787A (en) * | 1997-02-21 | 2000-06-27 | Abbott Laboratories | Methods for reducing the incidence of necrotizing enterocolitis |
CN1200701C (zh) | 1997-02-21 | 2005-05-11 | 艾博特公司 | 降低坏死性小肠结肠炎发生率的组合物 |
SE9702630D0 (sv) * | 1997-07-07 | 1997-07-07 | Scotia Lipidteknik Ab | Satiety product |
US6294206B1 (en) * | 1999-04-09 | 2001-09-25 | Abbott Laboratories | Powdered human milk fortifier |
US6495599B2 (en) | 2000-04-13 | 2002-12-17 | Abbott Laboratories | Infant formulas containing long-chain polyunsaturated fatty acids and uses therof |
EP1181870A1 (fr) * | 2000-08-22 | 2002-02-27 | Belovo Eggs & Egg Products | Emulsion de lipides constituant une source alimentaire de vitamine F plus equilibrée |
JP2003048831A (ja) | 2001-08-02 | 2003-02-21 | Suntory Ltd | 脳機能の低下に起因する症状あるいは疾患の予防又は改善作用を有する組成物 |
PT1542670E (pt) * | 2002-09-24 | 2013-07-11 | Suntory Holdings Ltd | Composição com efeitos na prevenção do declínio, melhoramento ou aumento de respostas normais de aptidões cognitivas de uma pessoa saudável |
EP1643862A1 (fr) * | 2003-06-24 | 2006-04-12 | University of Kansas Medical Center | Formule pour bebes |
JP4993852B2 (ja) | 2004-09-17 | 2012-08-08 | サントリーホールディングス株式会社 | ストレスに起因する行動異常を伴う症状あるいは疾患の予防又は改善作用を有する組成物 |
JP5967855B2 (ja) | 2005-06-30 | 2016-08-10 | サントリーホールディングス株式会社 | 日中活動量の低下および/又はうつ症状の改善作用を有する組成物 |
CA2662260C (fr) * | 2006-08-29 | 2015-10-27 | Martek Biosciences Corporation | Utilisation d'huiles dpa(n-6) dans une formule pour enfant en bas age |
EP3593797A1 (fr) | 2006-12-28 | 2020-01-15 | Suntory Holdings Limited | Agent de régénération des nerfs |
CN101909467B (zh) | 2007-11-01 | 2013-04-24 | 恩兹默泰克有限公司 | 用于婴儿营养的脂质混合物 |
EP2100897A1 (fr) * | 2008-01-30 | 2009-09-16 | BNLfood Investments SARL | Composition à base de lécithine et son utilisation dans les aliments |
EP2258216A1 (fr) * | 2009-06-02 | 2010-12-08 | Nestec S.A. | Composition nutritionnelle pour supporter le développement cérébral et fonction des tout-petits |
EP2554058A4 (fr) | 2010-03-31 | 2013-12-25 | Vegenat S A | Complément alimentaire fonctionnel spécialement destiné à la nutrition, à la prévention et à l'atténuation d'altérations neurologiques ou neurodégénératives ou de troubles cognitifs |
WO2011121150A1 (fr) | 2010-03-31 | 2011-10-06 | Vegenat, S.A. | Produit alimentaire entéral ou oral spécialement destiné à la nutrition, à la prévention et à l'atténuation d'altérations neurologiques ou neurodégénératives ou de troubles cognitifs |
WO2015069097A1 (fr) | 2013-11-08 | 2015-05-14 | N.V. Nutricia | Efficacité du dha alimentaire-phospholipide pour l'accrétion de dha et dpa dans le cerveau du nouveau-né |
WO2021058632A1 (fr) | 2019-09-24 | 2021-04-01 | Société des Produits Nestlé SA | Glycyrrhiza et prévention de l'oxydation des lc-pufa |
JP2023530076A (ja) | 2020-06-17 | 2023-07-13 | ソシエテ・デ・プロデュイ・ネスレ・エス・アー | コーヒー生豆の脱カフェイン処理に由来するサイドストリーム生成物によるlc-pufaの安定化 |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ES2033193B1 (es) * | 1990-10-30 | 1994-01-16 | Ganadera Union Ind Agro | Mezcla grasa para nutricion infantil y de adultos. |
ZA92452B (en) * | 1991-01-24 | 1992-10-28 | Martek Corp | Microbial oil mixtures and uses thereof |
SE9101642D0 (sv) * | 1991-05-30 | 1991-05-30 | Kabi Pharmacia Ab | Phospholipids |
DE4219360C2 (de) * | 1992-06-12 | 1994-07-28 | Milupa Ag | Verfahren zur Gewinnung von Lipiden mit einem hohen Anteil von langkettig-hochungesättigten Fettsäuren |
DE4407917C2 (de) * | 1993-03-15 | 2002-12-12 | Sueddeutsche Kalkstickstoff | Verfahren zur Gewinnung von Lipidfraktionen aus pulverförmigen Eiprodukten |
DE19505305A1 (de) * | 1994-02-24 | 1995-08-31 | Milupa Ag | Stabilisierte Lipidzusammensetzung mit langkettig-hochungesättigten Fettsäuren |
-
1995
- 1995-10-02 ES ES95934657T patent/ES2118629T3/es not_active Expired - Lifetime
- 1995-10-02 AT AT95934657T patent/ATE167983T1/de active
- 1995-10-02 CA CA002201931A patent/CA2201931C/fr not_active Expired - Fee Related
- 1995-10-02 DE DE59502779T patent/DE59502779D1/de not_active Expired - Lifetime
- 1995-10-02 WO PCT/EP1995/003899 patent/WO1996010922A1/fr active IP Right Grant
- 1995-10-02 DK DK95934657T patent/DK0784437T3/da active
- 1995-10-02 EP EP95934657A patent/EP0784437B1/fr not_active Expired - Lifetime
- 1995-10-02 JP JP8512316A patent/JPH10508193A/ja not_active Withdrawn
Non-Patent Citations (1)
Title |
---|
See references of WO9610922A1 * |
Also Published As
Publication number | Publication date |
---|---|
ATE167983T1 (de) | 1998-07-15 |
ES2118629T3 (es) | 1998-09-16 |
EP0784437B1 (fr) | 1998-07-08 |
DK0784437T3 (da) | 1999-04-19 |
DE59502779D1 (de) | 1998-08-13 |
CA2201931A1 (fr) | 1996-04-18 |
CA2201931C (fr) | 2004-08-10 |
WO1996010922A1 (fr) | 1996-04-18 |
JPH10508193A (ja) | 1998-08-18 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP0784437B1 (fr) | Melange de graisses contenant des phospholipides avec des acides gras polyinsatures a longue chaine | |
EP0231904B1 (fr) | Mélange gras riche en acides polyéniques et son utilisation dans la préparation d'aliments pour nourrissons | |
EP0404058B1 (fr) | Mélange gras, procédé pour sa préparation et son application | |
DE60125176T2 (de) | Verbesserte verfahren zum hinzufuegen mehrfach gesaettigter fettsaeuren in milch | |
DE69727138T2 (de) | Dietetische baby nahrungsmittel mit konjugierten linoleinsäuren | |
DE3787503T2 (de) | Fette und Öle mit einer verbesserten Verdaulichkeit und Absorptionsfähigkeit. | |
DE69636307T2 (de) | Erhöhung des hdl-spiegels und des hdl/ldl verhältnisses im menschlichen serum durch eine ausbalancierte mischung gesättigter und mehrfach ungesättigter diätfettsäuren | |
DE69823548T2 (de) | Verwendung von mehrfach ungesättigten fettsäuren zur vorbeugung von nekrotizierender enterokolitis | |
DE68907477T2 (de) | Essbare Öl-/Fett-Zusammensetzungen. | |
EP1041896B1 (fr) | Melange de corps gras | |
DE69735278T3 (de) | Verfahren zur Herstellung von ungesättigte Fettsäuren enthaltendem Öl | |
DE2127134A1 (de) | Fettpraparate fur Nahrungsmittel, Verfahren zu ihrer Herstellung und ihrer Verwendung | |
DE3877792T2 (de) | Verfahren zur zubereitung einer emulgierten fett-zusammensetzung. | |
DE2650980C2 (de) | Verfahren zur Herstellung eines Aufstrichmittels mit niedrigem Kaloriengehalt | |
DE68919712T2 (de) | Strukturiertes Lipid enthaltend Milchfett. | |
DE60132523T2 (de) | Pharmazeutische- und Nahrungsmittelzusammensetzungen mit "Holzalkohol" und "Holzsterol" zur Senkung des Serumcholesterins | |
DE60005911T2 (de) | Kuhmilch und Kuhfutter um eine solche Milch zu erhalten | |
EP0148303A1 (fr) | Composition diététique | |
WO1992020241A1 (fr) | Preparation de substances nutritives | |
DE3230103C2 (fr) | ||
DE19956400B4 (de) | Therapeutisch wirksame Zusammensetzung, ein Verfahren zu ihrer Herstellung und ihre Verwendung | |
DE19516982C2 (de) | Verwendung einer Milchkuh-Futterzusammensetzung | |
DE69103554T2 (de) | Essbare Emulsionen. | |
DE19505305A1 (de) | Stabilisierte Lipidzusammensetzung mit langkettig-hochungesättigten Fettsäuren | |
DE1792636A1 (de) | Verfahren zur Herstellung von Nahrungsmitteln |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PUAI | Public reference made under article 153(3) epc to a published international application that has entered the european phase |
Free format text: ORIGINAL CODE: 0009012 |
|
17P | Request for examination filed |
Effective date: 19970430 |
|
AK | Designated contracting states |
Kind code of ref document: A1 Designated state(s): AT BE CH DE DK ES FR GB GR IE IT LI LU NL PT |
|
GRAG | Despatch of communication of intention to grant |
Free format text: ORIGINAL CODE: EPIDOS AGRA |
|
17Q | First examination report despatched |
Effective date: 19971008 |
|
GRAG | Despatch of communication of intention to grant |
Free format text: ORIGINAL CODE: EPIDOS AGRA |
|
GRAH | Despatch of communication of intention to grant a patent |
Free format text: ORIGINAL CODE: EPIDOS IGRA |
|
GRAH | Despatch of communication of intention to grant a patent |
Free format text: ORIGINAL CODE: EPIDOS IGRA |
|
GRAA | (expected) grant |
Free format text: ORIGINAL CODE: 0009210 |
|
ITF | It: translation for a ep patent filed |
Owner name: BARZANO' E ZANARDO MILANO S.P.A. |
|
AK | Designated contracting states |
Kind code of ref document: B1 Designated state(s): AT BE CH DE DK ES FR GB GR IE IT LI LU NL PT |
|
REF | Corresponds to: |
Ref document number: 167983 Country of ref document: AT Date of ref document: 19980715 Kind code of ref document: T |
|
REG | Reference to a national code |
Ref country code: CH Ref legal event code: EP |
|
REG | Reference to a national code |
Ref country code: CH Ref legal event code: NV Representative=s name: TROESCH SCHEIDEGGER WERNER AG |
|
GBT | Gb: translation of ep patent filed (gb section 77(6)(a)/1977) |
Effective date: 19980710 |
|
REF | Corresponds to: |
Ref document number: 59502779 Country of ref document: DE Date of ref document: 19980813 |
|
REG | Reference to a national code |
Ref country code: ES Ref legal event code: FG2A Ref document number: 2118629 Country of ref document: ES Kind code of ref document: T3 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: LU Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 19981002 |
|
REG | Reference to a national code |
Ref country code: IE Ref legal event code: FG4D Free format text: GERMAN |
|
REG | Reference to a national code |
Ref country code: PT Ref legal event code: SC4A Free format text: AVAILABILITY OF NATIONAL TRANSLATION Effective date: 19980709 |
|
ET | Fr: translation filed | ||
REG | Reference to a national code |
Ref country code: DK Ref legal event code: T3 |
|
PLBE | No opposition filed within time limit |
Free format text: ORIGINAL CODE: 0009261 |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: NO OPPOSITION FILED WITHIN TIME LIMIT |
|
26N | No opposition filed | ||
REG | Reference to a national code |
Ref country code: GB Ref legal event code: IF02 |
|
PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] |
Ref country code: DK Payment date: 20141027 Year of fee payment: 20 Ref country code: PT Payment date: 20140403 Year of fee payment: 20 |
|
PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] |
Ref country code: CH Payment date: 20141024 Year of fee payment: 20 Ref country code: ES Payment date: 20141024 Year of fee payment: 20 Ref country code: DE Payment date: 20141124 Year of fee payment: 20 Ref country code: IE Payment date: 20141021 Year of fee payment: 20 Ref country code: FR Payment date: 20141021 Year of fee payment: 20 Ref country code: GR Payment date: 20141024 Year of fee payment: 20 Ref country code: GB Payment date: 20141024 Year of fee payment: 20 |
|
PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] |
Ref country code: AT Payment date: 20141022 Year of fee payment: 20 Ref country code: NL Payment date: 20141023 Year of fee payment: 20 |
|
PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] |
Ref country code: IT Payment date: 20141023 Year of fee payment: 20 |
|
PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] |
Ref country code: BE Payment date: 20141020 Year of fee payment: 20 |
|
REG | Reference to a national code |
Ref country code: DE Ref legal event code: R071 Ref document number: 59502779 Country of ref document: DE |
|
REG | Reference to a national code |
Ref country code: DK Ref legal event code: EUP Effective date: 20151002 |
|
REG | Reference to a national code |
Ref country code: NL Ref legal event code: MK Effective date: 20151001 |
|
REG | Reference to a national code |
Ref country code: PT Ref legal event code: MM4A Free format text: MAXIMUM VALIDITY LIMIT REACHED Effective date: 20151002 |
|
REG | Reference to a national code |
Ref country code: CH Ref legal event code: PL |
|
REG | Reference to a national code |
Ref country code: GB Ref legal event code: PE20 Expiry date: 20151001 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: GB Free format text: LAPSE BECAUSE OF EXPIRATION OF PROTECTION Effective date: 20151001 |
|
REG | Reference to a national code |
Ref country code: AT Ref legal event code: MK07 Ref document number: 167983 Country of ref document: AT Kind code of ref document: T Effective date: 20151002 |
|
REG | Reference to a national code |
Ref country code: IE Ref legal event code: MK9A |
|
REG | Reference to a national code |
Ref country code: ES Ref legal event code: FD2A Effective date: 20160126 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: IE Free format text: LAPSE BECAUSE OF EXPIRATION OF PROTECTION Effective date: 20151002 |
|
REG | Reference to a national code |
Ref country code: GR Ref legal event code: MA Ref document number: 980402055 Country of ref document: GR Effective date: 20151003 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: PT Free format text: LAPSE BECAUSE OF EXPIRATION OF PROTECTION Effective date: 20151009 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: ES Free format text: LAPSE BECAUSE OF EXPIRATION OF PROTECTION Effective date: 20151003 |